Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$16.32 - $26.37 $428,089 - $691,711
26,231 Added 254.82%
36,525 $707,000
Q2 2022

Aug 15, 2022

SELL
$18.54 - $37.29 $254,405 - $511,693
-13,722 Reduced 57.14%
10,294 $204,000
Q1 2022

May 16, 2022

SELL
$23.94 - $33.74 $517,870 - $729,863
-21,632 Reduced 47.39%
24,016 $716,000
Q4 2021

Feb 14, 2022

SELL
$21.19 - $31.29 $438,082 - $646,889
-20,674 Reduced 31.17%
45,648 $1.06 Million
Q3 2021

Nov 15, 2021

SELL
$27.36 - $35.98 $716,175 - $941,812
-26,176 Reduced 28.3%
66,322 $2.07 Million
Q2 2021

Aug 11, 2021

BUY
$28.9 - $36.87 $1.17 Million - $1.5 Million
40,571 Added 78.13%
92,498 $3.25 Million
Q1 2021

May 17, 2021

BUY
$32.03 - $42.85 $515,811 - $690,056
16,104 Added 44.95%
51,927 $1.83 Million
Q4 2020

Feb 16, 2021

BUY
$31.56 - $42.16 $560,221 - $748,382
17,751 Added 98.22%
35,823 $1.34 Million
Q3 2020

Nov 16, 2020

SELL
$23.19 - $41.61 $149,459 - $268,176
-6,445 Reduced 26.29%
18,072 $603,000
Q2 2020

Aug 14, 2020

BUY
$14.82 - $29.92 $363,341 - $733,548
24,517 New
24,517 $649,000
Q2 2018

Aug 14, 2018

SELL
$28.9 - $37.31 $907,893 - $1.17 Million
-31,415 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$26.78 - $39.35 $841,293 - $1.24 Million
31,415 New
31,415 $1.02 Million

Others Institutions Holding ALBO

About ALBIREO PHARMA, INC.


  • Ticker ALBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,612,500
  • Description
  • Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...
More about ALBO
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.